treatment | Page 46 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

treatment

  1. Home

Areej El-Jawahri, MD

El-Jawahri, Areej
Associate Director, Cancer Outcomes Research and Education Program
Massachusetts General Hospital

Dr. El-Jawahri is an oncologist specializing in the care of patients with hematologic malignancies and those undergoing hematopoietic stem cell transplantation. Clinically, she takes care of patients with acute leukemia, myelodysplastic syndrome, chronic leukemias, lymphomas, and myelomas.

Online Profile: 
Associate Director, Cancer Outcomes Research and Education Program Director, Bone Marrow Transplant Survivorship Program

Carlo Dufour, MD

Dufour, Carlo
Chair, Hemo-Onco- HSCT Department and the Hematology Unit
G. Gaslini Research Children’s Hospital, Genova, Italy

Carlo Dufour works in G.Gaslini Research Children’s Hospital, Genova, Italy, the largest, multi specialist pediatric hospital of the country, where he chairs the Hemo-Onco- HSCT Department and the Hematology Unit where have seat the national Registry of

Online Profile: 
Chair, Hemo-Onco- HSCT Department and the Hematology Unit

Press Release Gamida Cell Announces FDA Acceptance of Biologics License Application for Omidubicel with Priority Review

BOSTON--(BUSINESS WIRE)--Aug. 1, 2022-- Gamida Cell Ltd. (Nasdaq: GMDA), the leader in the development of NAM-enabled cell therapy candidates for patients with hematologic and solid cancers and other serious diseases, announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company’s Biologics License Application (BLA) for omidubicel for the treatment of patients with blood cancers in need of an allogenic hematopoietic stem cell transplant.